Targeted Medical Pharma Agrees To Sponsor A Clinical Trial Conducted By The United States Army And Henry M. Jackson Foundation For The Advancement Of Military Medicine
7/28/2014 10:22:55 AM
LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the completion of an agreement to sponsor an investigator-initiated study with the United States Army and The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF). The study, which is slated to start enrolling patients in Q2 of 2014, will involve the Company’s medical food Theramine.
Help employers find you! Check out all the jobs and post your resume.
comments powered by